Characteristics of subjective cognitive decline associated with amyloid positivity - Janssen, Olin (Maastricht University. School for Mental Health and Neuroscience) ; Jansen, W.J. (Maastricht University. School for Mental Health and Neuroscience) ; Vos, S.J.B. (Maastricht University. School for Mental Health and Neuroscience) ; Boada, Mercè (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ; Parnetti, Lucilla (Section of Neurology. Center for Memory Disturbances - Lab. of Clinical Neurochemistry. Department of Medicine and Surgery. University of Perugia) ; Gabryelewicz, T. (Department of Neurodegenerative Disorders. Mossakowski Medical Research Centre. Polish Academy of Sciences) ; Fladby, T. (Department of Neurology. Akershus University Hospital) ; Molinuevo, José Luis (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Villeneuve, S. (Centre for Studies on Prevention of Alzheimer's Disease (StOP-AD) Centre) ; Hort, J. (International Clinical Research Center. St. Anne's University Hospital) ; Epelbaum, S. (Inserm Sorbonne Université. Inria. Aramis project-team. Paris Brain Institute - Institut du Cerveau (ICM)) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Engelborghs, Sebastiaan (Vrije Universiteit Brussel. (VUB) Brussels. and University of Antwerp) ; van der Flier, W.M. (Alzheimer Center Amsterdam. Department of Neurology. Amsterdam Neuroscience. Amsterdam UMC. Vrije Universiteit Amsterdam) ; Landau, S. (Helen Wills Neuroscience Institute. University of California) ; Popp, J. (Old Age Psychiatry. University Hospital of Lausanne) ; Wallin, Anders (Institute of Neuroscience and Physiology. Sahlgrenska Academy at University of Gothenburg) ; Scheltens, P. (Alzheimer Center Amsterdam. Department of Neurology. Amsterdam Neuroscience. Amsterdam UMC. Vrije Universiteit Amsterdam) ; Rikkert, M.O. (Department of Geriatric Medicine. Radboud Alzheimer Center. Radboud University Medical Center) ; Snyder, P.J. (Kingston. The University of Rhode Island) ; Rowe, C. (Department of Molecular Imaging & Therapy. Austin Health) ; Chételat, G.. (Institut National de la Santé et de la Recherche Médicale (Inserm)) ; Ruíz, A. (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ; Marquié, M. (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ; Chipi, E. (Section of Neurology. Center for Memory Disturbances - Lab. of Clinical Neurochemistry. Department of Medicine and Surgery. University of Perugia) ; Wolfsgruber, S. (Department of Neurodegenerative Diseases and Psychiatry. University Hospital Bonn) ; Heneka, M. (Department of Neurodegenerative Diseases and Psychiatry. University Hospital Bonn) ; Boecker, H. (Functional Neuroimaging Group. Department of Radiology. University Hospital Bonn) ; Peters, O. (Charité - Universitätsmedizin Berlin) ; Jarholm, J. (Department of Neurology. Akershus University Hospital) ; Rami, L. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Tort-Merino, A. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Binette, A.P. (Centre for Studies on Prevention of Alzheimer's Disease (StOP-AD) Centre) ; Poirier, J. (Centre for Studies on Prevention of Alzheimer's Disease (StOP-AD) Centre) ; Rosa-Neto, P. (Centre for Studies on Prevention of Alzheimer's Disease (StOP-AD) Centre) ; Cerman, J. (International Clinical Research Center. St. Anne's University Hospital) ; Dubois, B. (AP-HP. Hôpital de la Pitié Salpêtrière. Institute of Memory and Alzheimer's Disease (IM2A). Centre of excellence of neurodegenerative disease (CoEN). Department of Neurology) ; Teichmann, M. (AP-HP. Hôpital de la Pitié Salpêtrière. Institute of Memory and Alzheimer's Disease (IM2A). Centre of excellence of neurodegenerative disease (CoEN). Department of Neurology) ; Alcolea, Daniel (Institut d'Investigació Biomèdica Sant Pau) ; Fortea, Juan (Institut d'Investigació Biomèdica Sant Pau) ; Sánchez-Saudinós, María Belén (Institut d'Investigació Biomèdica Sant Pau) ; Ebenau, J. (Alzheimer Center Amsterdam. Department of Neurology. Amsterdam Neuroscience. Amsterdam UMC. Vrije Universiteit Amsterdam) ; Pocnet, C. (Old Age Psychiatry. University Hospital of Lausanne) ; Eckerström, M. (Institute of Neuroscience and Physiology. Sahlgrenska Academy at University of Gothenburg) ; Thompson, L. (Kingston. The University of Rhode Island) ; Villemagne, V. (Department of Psychiatry. University of Pittsburgh) ; Buckley, R. (righam and Women's Hospital (Boston, Estats Units d'Amèrica)) ; Burnham, S. (Section of Neurology. Center for Memory Disturbances - Lab. of Clinical Neurochemistry. Department of Medicine and Surgery. University of Perugia) ; Delarue, M. (Institut National de la Sant. et de la Recherche M.dicale (Inserm)) ; Freund-Levi, Yvonne (Department of Neurobiology. Care Sciences and Society. Karolinska Institutet) ; Wallin, Å.K. (Department of Clinical Sciences Malmö. Clinical Memory Research Unit. Lund University) ; Ramakers, I. (Maastricht University. School for Mental Health and Neuroscience) ; Tsolaki, Magda (George Papanicolaou General Hospital (Tessalònica, Grècia)) ; Soininen, H. (Institute of Clinical Medicine. Neurology. University of Eastern Finland) ; Hampel, H. (GRC no 21. Alzheimer Precision Medicine (AMP). AP-HP. Pitié-Salpêtrière Hospital. Sorbonne University) ; Spiru, L. (Geriatrics- Gerontology and Old Age Psychiatry. Alzheimer Unit. Ana Aslan International Foundation - Memory Center and Longevity Medicine) ; Tijms, B. (Maastricht University. School for Mental Health and Neuroscience) ; Ossenkoppele, R. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Verhey, F.R.J. (Maastricht University. School for Mental Health and Neuroscience) ; Jessen, Frank (German Center For Neurodegenerative Diseases/Clinical Research. Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE). Zentrum für klinische Forschung/AG) ; Visser, P.J. (Department of Neurobiology. Care Sciences and Society. Karolinska Institutet)